Exact Sciences on Path to Filing PMA for Cologuard in 2012

The company has begun enrollment for a trial and plans to recruit more than 10,000 patients, between ages 50 and 84, at average risk of colorectal cancer.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.